Histosonicsincis A Medical Technology Company Founded In 2009 By Scientists From The University Of Michiganthe Company Specializes In Histotripsya Non Thermal Therapeutic Ultrasound Technique That Precisely Destroys Targeted Tissue Within The Bodytheir Primary Producttheedisonrobotic Platformdelivers Histotripsy Treatments And Is Particularly Effective For Non Invasive Treatment Of Liver Tumors Under The Leadership Of President And Ceo Mike Bluehistosonics Has Made Significant Strategic Advancements Since 2017Establishing Itself As A Leader In Histotripsythe Company Has Successfully Completed Clinical Trialsachieving Notable Outcomes Such As 90Local Tumor Control At 12 Months In The Hope4Liver Trialshistosonics Also Opened A New Manufacturing Facility In Minneapolis In 2019 And Has Received Multiple Innovation Awards For Its Technologythe Company Aims To Make Histotripsy A Widely Accepted Treatment Optionbenefiting Both Physicians And Patients Globally
United States
